|
Content and method of the compensation and the shareholding
programs
Executive compensation policy and programs
Syngenta’s executive compensation principles are
designed to attract, retain and motivate internationally
oriented, successful executives. They aim is to provide
appropriate rewards in a competitive employment market
and support the development of a high performance environment.
The
elements of total compensation for the Chairman, Chief
Executive Officer, members of the Executive Committee
and the Senior Management Group are base salary, annual
cash and equity based incentive awards.
Total
individual compensation at target performance level relates
to market median for comparable companies with the possibility
of substantial higher compensation for outstanding performance.
The incentive awards generally represent a significant
part of total compensation. Cash and equity incentive
awards are based on Company and individual performance.
Equity based compensation consists of stock options for
the long-term incentive award and share awards for a
portion of the short-term incentive award.
Equity based compensation programs
Syngenta’s equity based compensation programs encourages
the participants to focus on the performance and long-term
growth of the company, aligns the interests of the participants
with those of Syngenta shareholders and allows participants
to share in the long-term success of Syngenta.
Syngenta
Long-Term Incentive
Plan (stock options)
The
number of options
granted to a participant
is based on target
long-term incentive,
performance and option
value. The Black-Scholes
model, a commonly
accepted stock option
valuation method,
is used to determine
the value of an option.
The value of the
awarded long-term
incentive is divided
by the option value
to give the number
of options. After
a three-year blocking
period, options can
be exercised to purchase
Syngenta shares within
ten or eleven years
from the date of
grant.
Syngenta Deferred Share Plan
According
to the rules of the plan a portion of the annual short-term
incentive award will mandatorily be allocated into
the Deferred Share Plan. In addition, a certain portion
of the annual short-term incentive award may voluntarily
be deferred into the plan. After a three-year deferral
period, the deferred shares become freely tradable
Syngenta shares. At the end of the deferral period,
Syngenta matches on a one-for-one basis the deferred
shares, doubling the total number of shares. The value
of a deferred share at the time of the grant corresponds
to the Syngenta share price at the time of the grant.
Syngenta Employee Share Purchase Plan
All
Syngenta employees in Switzerland, including the Chairman,
Chief Executive Officer and members of the Executive
Committee can participate in the Syngenta Employee
Share Purchase Plan. This plan entitles employees to
subscribe once a year to shares at a discount rate
of 50 per cent from the closing price at the grant
date.
The
maximum subscription per employee per year is limited
to a total value of CHF 5,000. The shares have a blocking
period of three years.
Compensation for members of the
Board of Directors
and the Executive Committee
2003 Executive compensation
The
aggregate amount of cash compensation (salaries and
bonuses) in 2003 to the Chairman, the Chief Executive
Officer and the members of Executive Committee (a total
of 10 people, including John Elias, former Head of
Human Resources who resigned from the Company at the
end of September 2003) amounted to CHF 10,280,685.
In addition, CHF 4,499,874 was set aside to meet pension
obligations, including provisions to cover merger-related
pension promises.
As of December 31, 2003, the Chairman, Chief Executive
Officer and members of the Executive Committee held 608,128
options on shares of Syngenta AG. (See
table 1)
Furthermore, as of December 31, 2003, the aggregate
number of shares of Syngenta AG held by the Chairman,
Chief Executive Officer and the members of the Executive
Committee, including parties closely linked, was 36,853.
Parties closely linked are (i) their spouses, (ii) their
children below age 18, (iii) any legal entities that
they own or otherwise control, and (iv) any legal or
natural person who is acting as their fiduciary.
The
Syngenta Deferred Share Plan was first introduced in
2002 for voluntary deferrals of the 2002 short-term
incentive awards. The total amount of the 2002 short-term
incentive award voluntarily deferred in 2003 by the
Chairman, Chief Executive Officer and members of the
Executive Committee results in 20,763 deferred shares.
In 2003, within the scope of the Syngenta Employee Share
Purchase Plan, the Chairman, Chief Executive Officer
and members of the Executive Committee purchased 594
shares.
2003 Non-Executive Director compensation
Each
Non-Executive Director could opt for payment in cash
or a combination of cash and options. The aggregate
amount of compensation in 2003 to the ten Non-Executive
Directors (cash compensation and options) amounted
to CHF 1,630,000. CHF 1,161,000 was paid in cash and
CHF 469,000 will be paid in options. These options
will be issued in 2004 in accordance with the Company’s
Long-Term Incentive Plan. A total of 18,670 options,
which were part of the 2002 Non-Executive Director’s
compensation, were granted in 2003.
Directors are reimbursed for travel and other necessary
business expenses incurred in the performance of their
services.
As of December 31, 2003, the Non-Executive Directors
held 59,632 options on shares of Syngenta AG. (See
table 2)
Furthermore, as of December 31, 2003, the aggregate
number of shares of Syngenta AG held by Non-Executive
Directors, including parties closely linked, was 14,953.
Parties
closely linked are (i) their spouses, (ii) their children
below age 18, (iii) any legal entities that they own
or otherwise control, and (iv) any legal or natural person
who is acting as their fiduciary.
Table
1
 |
| Number of Options |
Year of Allocation
|
Exercise
Period |
Exercise
Price |
 |
| 164,000
|
2000
|
10 years
|
CHF 76.50 |
 |
| 13,500 |
2001
|
10 years |
CHF 83.70 |
 |
| 56,473 |
2002 |
10 years |
CHF 98.00 |
 |
| 102,806 |
2002 |
11 years |
CHF 98.00 |
 |
| 94,249 |
2003 |
10 years |
CHF 59.70 |
 |
| 177,100 |
2003 |
11 years |
CHF 59.70 |
 |
Table 2
 |
| Number of Options |
Year of Allocation
|
Exercise
Period |
Exercise
Price |
 |
| 25,000 |
2000 |
10 years
|
CHF 76.50 |
 |
|
2001 |
10 years |
CHF 83.70 |
 |
| 3,425 |
2002 |
10 years |
CHF 98.00 |
 |
| 12,537 |
2002 |
11 years |
CHF 98.00 |
 |
|
2003 |
10 years |
CHF 59.70 |
 |
| 18,670 |
2003 |
11 years |
CHF 59.70 |
 |
The
exercise price is equal to the weighted average share
price on the Swiss stock exchange (SWX) for the five business
days preceding the grant date, as determined by the Compensation
Committee. All of the options vest in full and are exercisable
after three years. Each option gives the holder the right
to purchase one registered share of Syngenta AG.
Compensation for former members of the Board of
Directors and the Executive Committee
The aggregate amount of cash compensation (salaries
and bonuses) in 2003 to a former member of the Executive
Committee amounted to CHF 385,000. In addition, CHF 25,850
was set aside to meet pension obligations.
No
compensation was made to former members of the Board
of Directors.
Share allotment
This information is contained in Compensation
for members of the Board of Directors and the Executive
Committee .
Share
ownership
This information is contained in Compensation
for members of the Board of Directors and the Executive
Committee .
Options
This information is contained in section Compensation
for members of the Board of Directors and the Executive
Committee .
Additional fees and remuneration
No material additional honorarium and remuneration were
paid to any member of the Board of Directors or the Executive
Committee.
Severance payments and loans
There were no loans granted to the members of the Board
of Directors or Executive Committee during the year under
review, and as of December 31, 2003, there were no loans
outstanding. During the year under review, the aggregate
amount of severance payments to a former member of the
Executive Committee amounted to CHF 342,800.
No
severance payments were made to former members of the
Board of Directors.
Highest total compensation
The highest total compensation paid to a member of the
Board of Directors in the year under review consisted
of CHF 2,091,031 of cash compensation (salary and bonus).
In
addition 66,809 options under the Syngenta Long-Term
Incentive Plan (Stock Options) and 5,495 deferred shares
under the Syngenta Deferred Share Plan were granted to
this member of the Board of Directors. Furthermore, 66
shares were purchased by this member of the Board of
Directors under the Employee Share Purchase Plan. CHF
3,187,178 was set aside to meet pension obligations,
including provisions to cover merger-related pension
promises.
|